CompletedNot Applicable

The Nordic Bifurcation Study III

Denmark477 participantsStarted 2007-04-02

Plain-language summary

Should we, or should we not, perform dilatation of the side branch through the main vessel stent, if there is acceptable blood flow in the side branch?

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Stable or unstable angina pectoris. -Bifurcation lesion of "LAD/diagonal", "Cx/obtuse marginal", "RCA-- * PDA/posterola¬te¬ral branch" or "LM/Cx/LAD". * Diameter of main vessel by visual estimate \> 2.5 mm. * Diameter of side branch by visual estimate \> 2.25 mm. * Signed informed consent Exclusion Criteria: * Age \< 18 years. * ST-elevation infarction within 24 hours. * Expected survival \< 1 year. * S-creatinine \> 200 µmol/l. * Allergy to Aspirin, Clopidogrel or Ticlopidine. * Allergy to Sirolimus.

What they're measuring

Combined end point of: cardiac death, index lesion myocardial infarction, stent thrombosis or target lesion revascularisation

Timeframe: After 6 months

Trial details

NCT IDNCT00914199

SponsorEvald Hoej Christiansen

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2008-09

View on ClinicalTrials.gov More Coronary Artery Disease trials